Lv1
30 积分 2022-08-03 加入
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
1天前
待确认
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
4天前
已完结
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non–Small-Cell Lung Cancer
8天前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
9天前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
9天前
已完结
Clinicopathological and molecular differences in colorectal cancer according to location
16天前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
23天前
已完结
Has Colorectal Cancer (c-)Met Its Match With Telisotuzumab Adizutecan?
23天前
已关闭
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
24天前
已完结
Colorectal cancer
24天前
已完结
皖公网安备34019202002308
